LBO-001 Norucholic acid for the treatment of primary sclerosing cholangitis: 96-week analysis of a pivotal phase 3 trial

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-05-01 DOI:10.1016/S0168-8278(25)00310-1

Michael Trauner, Palak J. Trivedi, Gerald Denk, Martti Färkkilä, Peter Schirmacher, Stefan G. Hübscher, Michael Dill, Gerda Elisabeth Villadsen, Christoph P. Berg, Kristin K. Jørgensen, Marcel Vetter, Münevver Demir, Andreas E. Kremer, Christoph Schramm, Christian Strassburg, Heike Bantel, Tobias Böttler, Ulrich Beuers, Alexandre Louvet, Emina Halilbasic, Michael P. Manns

引用次数: 0

查看原文本刊更多论文

LBO-001诺胆酸治疗原发性硬化性胆管炎：一项关键的3期试验的96周分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.